Search Results - "Fallatah, Maryam M."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
  2. 2

    Pyrimidine Triones as Potential Activators of p53 Mutants by Fallatah, Maryam M Jebril, Demir, Özlem, Law, Fiona, Lauinger, Linda, Baronio, Roberta, Hall, Linda, Bournique, Elodie, Srivastava, Ambuj, Metzen, Landon Tyler, Norman, Zane, Buisson, Rémi, Amaro, Rommie E, Kaiser, Peter

    Published in Biomolecules (Basel, Switzerland) (08-08-2024)
    “…p53 is a crucial tumor suppressor in vertebrates that is frequently mutated in human cancers. Most mutations are missense mutations that render p53 inactive in…”
    Get full text
    Journal Article
  3. 3

    Small-molecule correctors and stabilizers to target p53 by Fallatah, Maryam M.J., Law, Fiona V., Chow, Warren A., Kaiser, Peter

    “…The tumor suppressor p53 is among the most attractive precision oncology targets. The two main small-molecule-based approaches for targeting p53 are blocking…”
    Get full text
    Journal Article
  4. 4

    Enantiomer of the novel flexible heteroarotinoid, SL-1-09, blocks cell cycle progression in breast cancer cells by Ginn, Emily, Baek, Jihyun, Zou, Hongye, Fallatah, Maryam M.J., Liu, Shengquan, Sevigny, Mary B., Louie, Maggie

    Published in European journal of pharmacology (05-11-2019)
    “…Flexible heteroarotinoids (Flex-Hets) are compounds with promising anti-cancer activities. SHetA2, a first-generation Flex-Het, has been shown to inhibit the…”
    Get full text
    Journal Article
  5. 5

    Novel flexible heteroarotinoid, SL-1-18, promotes ERα degradation to inhibit breast cancer cell growth by Fallatah, Maryam M., Liu, Shengquan, Sevigny, Mary B., Zou, Hongye, Louie, Maggie C.

    Published in Cancer letters (01-11-2017)
    “…SL-1-18 (1-(chrysen-6-yl)-3-(4-nitrophenyl)thiourea) is new flexible heteroarotinoid (Flex-Het) analog derived from the parent compound, SHetA2, and our…”
    Get full text
    Journal Article
  6. 6

    Abstract 113: Evaluating the anticancer activity of two flexible heteroarotinoid analogs on breast cancer by Ginn, Emily, Zou, Hongye, Fallatah, Maryam M., Liu, Shengquan, Louie, Maggie C.

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Abstract Flexible heteroarotiniods (flex-hets) are compounds derived from retinoic acid and recent studies have indicated that these compounds exhibit…”
    Get full text
    Journal Article